Skip to main content

Table 1 Clinical sources of the glioma cell lines used in this study

From: Malignancy-associated metabolic profiling of human glioma cell lines using 1H NMR spectroscopy

Designation Source (Tumor stage) P53 gene mutation
CHG5 WHO II Unknown
SHG44 WHO II Wild-type[16]
U87 WHO IV Wild-type[17]
U118 WHO IV Mutation[18]
U251 WHO IV Mutation[16]